SIGLEC5: reading sialic-acid identity with an inhibitory receptor

Innate immune restraint, paired-Siglec complexity, and the meaning of UC hypomethylation

Function

SIGLEC-5 is a sialic-acid-binding receptor expressed mainly on myeloid cells. Its cytoplasmic inhibitory motifs recruit phosphatases that dampen activation when the receptor engages appropriate sialylated ligands. It operates in a complicated locus alongside activating SIGLEC-14, whose similar extracellular region can complicate interpretation.

Inhibitory signal intact

Myeloid activation is tuned rather than simply switched on.

→

SIGLEC5 reduced

Inhibitory tone may fall, but phenotype depends on ligands, cell type, and SIGLEC14 genotype/expression.

Relevance here

Hypomethylation in inflamed UC tissue could reflect altered regulation or more SIGLEC5-expressing myeloid cells. Bulk methylation cannot distinguish these explanations. Expression, cell deconvolution, and locus-aware genotyping are important.

The paired-receptor complication

SIGLEC-5 carries inhibitory ITIM motifs, whereas the closely related SIGLEC-14 signals through DAP12. Human genetic variation can produce a SIGLEC14-null fusion genotype, changing the balance between receptors with similar ligand-binding domains. Functional work with group B Streptococcus showed that this paired system can alter neutrophil inflammatory responses (Ali, Fong, Carlin, and others, 2014).

Consequence for a UC biomarker

An assay that does not resolve cell type and the SIGLEC5/SIGLEC14 locus can misattribute both methylation and expression. The most informative design combines genotype-aware mapping, neutrophil/monocyte abundance, receptor-specific protein reagents, ligand sialylation, and downstream phosphatase or DAP12 signaling.

Why “less methylation = more inhibition” is too simple

The CpG may not control the promoter, RNA may not track it, receptor occupancy matters, and the paired activating Siglec changes the biological balance.

Back to the gene overview → · NCBI Gene →

References

S. R. Ali, J. J. Fong, A. F. Carlin, and others. (2014). Siglec-5 and siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group b streptococcus. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20131853.